MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-02-2023
NuVasive Operating Expenses 2011-2026 | NUVA
Annual Operating Expenses NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 777 M | 829 M | 691 M | 735 M | 688 M | 638 M | 624 M | 513 M | 521 M | 472 M | 420 M | 394 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 829 M | 394 M | 608 M |
Quarterly Operating Expenses NuVasive
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 210 M | 214 M | - | 193 M | 192 M | 200 M | - | 189 M | 206 M | 187 M | - | 184 M | 160 M | 160 M | - | 183 M | 184 M | 180 M | - | 179 M | 176 M | 205 M | - | 151 M | 164 M | 165 M | - | 159 M | 116 M | 149 M | - | 123 M | 129 M | 91.2 M | - | 126 M | 141 M | 162 M | - | 114 M | 117 M | 114 M | - | 98.1 M | 105 M | 108 M | - | 198 M | 96 M | 96.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 214 M | 91.2 M | 156 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.3 | -4.96 % | $ 6.38 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 166.05 | -6.36 % | $ 12.4 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Sensus Healthcare
SRTS
|
22.2 M | $ 3.79 | -5.61 % | $ 61.9 M | USA |
 |
Stryker Corporation
SYK
|
11.2 B | $ 328.87 | -1.15 % | $ 126 B | USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 10.97 | -4.78 % | $ 1.65 B | USA |
 |
Tactile Systems Technology
TCMD
|
221 M | $ 26.49 | -1.08 % | $ 606 M | USA |
 |
TELA Bio
TELA
|
88.1 M | $ 0.67 | -10.47 % | $ 31.5 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
139 M | $ 0.38 | 1.99 % | $ 39.1 M | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 104.91 | 0.33 % | $ 183 B | USA |
 |
Tandem Diabetes Care
TNDM
|
159 M | $ 21.24 | -8.92 % | $ 1.44 B | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 69.46 | -1.01 % | $ 103 B | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 35.4 | -3.38 % | $ 1.1 B | USA |
 |
Establishment Labs Holdings
ESTA
|
185 M | $ 56.7 | -5.36 % | $ 1.68 B |  Costa-rica |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
5.09 M | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Viemed Healthcare
VMD
|
55.7 M | $ 9.27 | 0.54 % | $ 361 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.61 | 1.65 % | $ 33.2 M | USA |
 |
Aethlon Medical
AEMD
|
9.34 M | $ 2.14 | -5.73 % | $ 3.34 M | USA |
 |
Varex Imaging Corporation
VREX
|
318 M | $ 10.82 | 0.32 % | $ 448 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 79.47 | -3.2 % | $ 46.5 B | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Beyond Air
XAIR
|
42.9 M | $ 0.72 | 4.06 % | $ 48.7 M | USA |
 |
Xtant Medical Holdings
XTNT
|
80.3 M | $ 0.55 | -2.12 % | $ 73.5 M | USA |
 |
Inogen
INGN
|
184 M | $ 6.29 | -3.31 % | $ 167 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
4.46 B | $ 88.46 | -0.77 % | $ 18 B | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 11.16 | -2.19 % | $ 1.51 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.81 | -3.3 % | $ 371 M | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
26.8 M | - | 10.0 % | $ 610 K | USA |